Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae
Open Access
- 31 May 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 60 (1) , 54-60
- https://doi.org/10.1093/jac/dkm166
Abstract
In Neisseria gonorrhoeae, the mosaic structure of penicillin-binding protein 2 (PBP 2), composed of fragments of PBP 2 from Neisseria cinerea and Neisseria perflava, was significantly associated with decreased susceptibility to cephalosporins, particularly oral cephalosporins. The aim of this study was to determine the affinity of mosaic PBP 2 for cephalosporins in N. gonorrhoeae. Two types of non-mosaic PBP 2 from the type strain of N. gonorrhoeae (ATCC 19424) and a clinical strain (GU01-29), as well as the mosaic PBP 2 from a clinical strain (GU01-89), were expressed in insect cells, and recombinant PBP 2s were purified. ATCC 19424 and GU01-29 were susceptible to cephalosporins. GU01-89 showed decreased susceptibility to cephalosporins. Bindings of fluorescent penicillin to PBP 2 were characterized by the Scatchard plot analysis. The affinity of the recombinant PBP 2s for cefdinir, cefixime and ceftriaxone was determined by PBP 2 competition assays with fluorescent penicillin. The Kd value of mosaic PBP 2 for fluorescent penicillin was higher than that of non-mosaic PBP 2s. The affinity of mosaic PBP 2 for cefdinir or cefixime was lower than that of the non-mosaic PBP 2s. The affinity of the mosaic PBP 2 for ceftriaxone was not changed, compared with that of the non-mosaic PBP 2s. Other mechanisms may be involved in clinical isolates with decreased susceptibility to cephalosporins, but this study suggests that the decreased affinity of mosaic-structure recombinant PBP 2 for oral cephalosporins may contribute to decreased susceptibility to these antibiotics in N. gonorrhoeae.Keywords
This publication has 31 references indexed in Scilit:
- Remarkable Increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae Isolates with Decreased Susceptibility to Penicillin, Tetracycline, Oral Cephalosporins, and FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2004
- Outbreak of Cefozopran (Penicillin, Oral Cephems, and Aztreonam)-Resistant Neisseria gonorrhoeae in JapanAntimicrobial Agents and Chemotherapy, 2001
- Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce β-lactamaseJournal of Infection and Chemotherapy, 2001
- Quinolone-Resistant Neisseria gonorrhoeaeJournal of Infection and Chemotherapy, 1997
- β-Lactam Antibiotic Resistance in Gram-Positive Bacterial Pathogens of the Upper Respiratory Tract: A Brief Overview of MechanismsMicrobial Drug Resistance, 1995
- Origin and molecular epidemiologY of penicillin-binding-protein-mediated resistance to β-lactam antibioticsTrends in Microbiology, 1994
- Genetics of resistance to third‐generation cephalosporins in clinical isolates of Streptococcus pneumoniaeMolecular Microbiology, 1992
- SERINE β-LACTAMASES AND PENICILLIN-BINDING PROTEINSAnnual Review of Microbiology, 1991
- Extensive re‐modelling of the transpeptidase domain of penicillin‐binding protein 2B of a penicillin‐resistant South African isolate of Streptococcus pneumoniaeMolecular Microbiology, 1989
- Properties of the Penicillin‐Binding Proteins of Escherichia coli K12European Journal of Biochemistry, 1977